Abstract:Vibrio vulnificus is a highly pathogenic Gram‐negative bacterium with high mortality rates, causing rapid‐onset infections that can lead to extensive tissue necrosis and septicemia, with fatality rates up to 50%. Although photodynamic therapy is a promising non‐invasive, cost‐effective antibacterial treatment, its application to V. vulnificus remains underexplored. This work presented a photosensitizer named BDTP with aggregation‐induced emission properties. BDTP targets V. vulnificus DNA. Under white light, BDTP causes phototoxic DNA damage to V. vulnificus and disrupts biofilms, while minimizing harm to host cells due to the cell membrane barrier. In infected mice, BDTP accelerates wound healing, offering a potential new approach in photo‐based theranostics for V. vulnificus infection treatment. Vibrio vulnificus is a highly virulent Gram‐negative bacterium exhibiting extensive resistance to various antibiotics, presenting significant challenges for efficient and selective eradication. Recently, photosensitizer (PS)‐based photodynamic therapy has emerged as an effective strategy against bacteria and biofilms. However, traditional PS struggles to penetrate the unique membrane structure of Gram‐negative bacteria such as V. vulnificus, while avoiding traversal of the membrane barrier of eukaryotic cells. To address this issue, herein, a PS named BDTP with aggregation‐induced emission properties was developed. BDTP can specifically target the DNA of V. vulnificus, but integrate into the cell membrane, preventing damage to the contents in eukaryotic cells due to its hydrophilic/lipophilic "Y‐shaped" structural characteristics. In dark conditions, BDTP functions as an antibiotic, inhibiting bacterial proliferation. Upon white light stimulation, BDTP can induce phototoxic damage to the DNA of V. vulnificus and effectively inhibit/clear V. vulnificus biofilms. Additionally, the eukaryotic cell membrane barrier significantly reduces PS‐induced damage to its nucleic acids. This strategy significantly promotes the healing of infected wounds in V. vulnificus‐infected mice. Our work introduces the first PS targeting V. vulnificus‐associated infections, demonstrating efficacy both in vitro and in vivo.

Photodynamic viral inactivation assisted by photosensitizers

Virus-Based Cancer Therapeutics for Targeted Photodynamic Therapy.

Efficient Inactivation of Enveloped Viruses Using a Nanoparticle-Based Photodynamic Method

Photoactive conjugated polymer-based strategy to effectively inactivate RNA viruses

Enhancement of Photodynamic Cancer Therapy by Physical and Chemical Factors

Recent advances in engineered polymeric materials for efficient photodynamic inactivation of bacterial pathogens

Rapid virus inactivation by nanoparticles-embedded photodynamic surfaces

Selective, broad-spectrum antiviral photodynamic disinfection with dicationic imidazolyl chlorin photosensitizers

Study of Viral Photoinactivation by UV-C Light and Photosensitizer Using a Pseudotyped Model

Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds

Photocatalytic Inactivation of Viruses Using Graphitic Carbon Nitride-Based Photocatalysts: Virucidal Performance and Mechanism

Latest trends on photodynamic disinfection of Gram-negative bacteria: photosensitizer’s structure and delivery systems

Photodynamic Inactivation of Multidrug-Resistant Staphylococcus aureus Using Hybrid Photosensitizers Based on Amphiphilic Block Copolymer-Functionalized Gold Nanoparticles

A systematic review of photodynamic therapy as an antiviral treatment: Potential guidance for dealing with SARS-CoV-2

Photoimmunotechnology as a powerful biological tool for molecular-based elimination of target cells and microbes, including bacteria, fungi and viruses

Gram‐Negative Bacteria Targeting AIE Photosensitizer for Selective Photodynamic Killing of Vibrio vulnificus

Photo-catalyzed TiO2 Inactivates Pathogenic Viruses by Attacking Viral Genome

Donor–acceptor (perylenethienyl)ethylenes as singlet oxygen photogenerating viral inhibitors

Antiviral photodynamic therapy: Inactivation and inhibition of SARS-CoV-2 in vitro using methylene blue and Radachlorin

BOPHY Derivatives as Phototherapeutic Agents for the Photodynamic Inactivation of Microorganisms

Photodynamic inactivation and its effects on the heterogeneity of bacterial resistance